
Febuxostat (40mg)
Active composition
Febuxostat inhibits the enzyme xanthine oxidase, thereby reducing the synthesis of uric acid in the body.
Medical applications
Goutfree 40 Tablet ER contains Febuxostat 40 mg, a xanthine oxidase inhibitor indicated for the management of hyperuricemia in patients with gout. Febuxostat selectively inhibits xanthine oxidase, the enzyme responsible for converting hypoxanthine to xanthine and xanthine to uric acid, thereby reducing serum uric acid levels. This extended-release formulation ensures a sustained therapeutic effect, promoting better patient compliance by maintaining steady plasma concentrations. Goutfree 40 is primarily prescribed for chronic gout management to prevent acute gout attacks and tophi formation by lowering uric acid levels below the saturation point. It is suitable for patients who are intolerant to or inadequately managed with allopurinol. Dosage should be individualized based on serum uric acid levels and renal function, with regular monitoring recommended. Common adverse effects may include liver function abnormalities, nausea, rash, and joint pain. Caution is advised in patients with cardiovascular disease or hepatic impairment. Goutfree 40 Tablet ER should be used under medical supervision, with attention to potential drug interactions and contraindications. Adequate hydration and lifestyle modifications complement pharmacotherapy for optimal gout management.
How to use Goutfree Tablet ER Take this medicine in the dose and duration as advised by your doctor. Swallow it as a whole. Do not chew, crush or break it. Goutfree 40 Tablet ER may be taken with or without food, but it is better to take it at a fixed time.
Important precautions
Based on clinical trials and patient reports.
Overall Tolerance
Common Side Effects
Caution is advised when consuming alcohol with Goutfree 40 Tablet ER. Please consult your doctor.
High Risk
Goutfree 40 Tablet ER may be unsafe to use during pregnancy. Although there are limited studies in humans, animal studies have shown harmful effects on the developing baby. Your doctor will weigh the benefits and any potential risks before prescribing it to you. Please consult your doctor.
Medical Advice
Goutfree 40 Tablet ER may cause side effects which could affect your ability to drive. Goutfree 40 Tablet ER may cause dizziness, sleepiness, blurred vision, numbness or tingling sensation. This may affect your driving ability.
Exercise Caution
Goutfree 40 Tablet ER should be used with caution in patients with severe liver disease. Dose adjustment of Goutfree 40 Tablet ER may be needed. Please consult your doctor. Limited information is available regarding the use of Goutfree 40 Tablet ER in these patients.
Regular Checkup
Goutfree 40 Tablet ER is probably unsafe to use during breastfeeding. Limited human data suggests that the drug may pass into the breastmilk and harm the baby.
Consult Doctor
Goutfree 40 Tablet ER should be used with caution in patients with severe kidney disease. Dose adjustment of Goutfree 40 Tablet ER may be needed. Please consult your doctor. Limited information is available regarding the use of Goutfree 40 Tablet ER in these patients.
Regular Checkup
0 reviews for Goutfree 40 Tablet ER

Febuxostat (40mg)
Cheaper alternative availability
This medicine doesn't have a cheaper alternative with the same composition. Our health advisors can help you find other savings options based on your prescription.
Active composition
Febuxostat inhibits the enzyme xanthine oxidase, thereby reducing the synthesis of uric acid in the body.
Medical applications
Goutfree 40 Tablet ER contains Febuxostat 40 mg, a xanthine oxidase inhibitor indicated for the management of hyperuricemia in patients with gout. Febuxostat selectively inhibits xanthine oxidase, the enzyme responsible for converting hypoxanthine to xanthine and xanthine to uric acid, thereby reducing serum uric acid levels. This extended-release formulation ensures a sustained therapeutic effect, promoting better patient compliance by maintaining steady plasma concentrations. Goutfree 40 is primarily prescribed for chronic gout management to prevent acute gout attacks and tophi formation by lowering uric acid levels below the saturation point. It is suitable for patients who are intolerant to or inadequately managed with allopurinol. Dosage should be individualized based on serum uric acid levels and renal function, with regular monitoring recommended. Common adverse effects may include liver function abnormalities, nausea, rash, and joint pain. Caution is advised in patients with cardiovascular disease or hepatic impairment. Goutfree 40 Tablet ER should be used under medical supervision, with attention to potential drug interactions and contraindications. Adequate hydration and lifestyle modifications complement pharmacotherapy for optimal gout management.
How to use Goutfree Tablet ER Take this medicine in the dose and duration as advised by your doctor. Swallow it as a whole. Do not chew, crush or break it. Goutfree 40 Tablet ER may be taken with or without food, but it is better to take it at a fixed time.
Important precautions
Based on clinical trials and patient reports.
Overall Tolerance
Common Side Effects
Caution is advised when consuming alcohol with Goutfree 40 Tablet ER. Please consult your doctor.
High Risk
Goutfree 40 Tablet ER may be unsafe to use during pregnancy. Although there are limited studies in humans, animal studies have shown harmful effects on the developing baby. Your doctor will weigh the benefits and any potential risks before prescribing it to you. Please consult your doctor.
Medical Advice
Goutfree 40 Tablet ER may cause side effects which could affect your ability to drive. Goutfree 40 Tablet ER may cause dizziness, sleepiness, blurred vision, numbness or tingling sensation. This may affect your driving ability.
Exercise Caution
Goutfree 40 Tablet ER should be used with caution in patients with severe liver disease. Dose adjustment of Goutfree 40 Tablet ER may be needed. Please consult your doctor. Limited information is available regarding the use of Goutfree 40 Tablet ER in these patients.
Regular Checkup
Goutfree 40 Tablet ER is probably unsafe to use during breastfeeding. Limited human data suggests that the drug may pass into the breastmilk and harm the baby.
Consult Doctor
Goutfree 40 Tablet ER should be used with caution in patients with severe kidney disease. Dose adjustment of Goutfree 40 Tablet ER may be needed. Please consult your doctor. Limited information is available regarding the use of Goutfree 40 Tablet ER in these patients.
Regular Checkup
0 reviews for Goutfree 40 Tablet ER















